COVID-19 Research and Resources
Research Ramp-up Resources
List of BI Procedures and Guidelines for Research Ramp-up
BI Research Ramp-Up
Refocusing Research Expertise and Accelerating New Collaborations
The members of the BI research community have refocused their research expertise to address the COVID-19 pandemic. Our researchers have pivoted their research projects and quickly formed new collaborations across campus and beyond to fight COVID-19 on many fronts. Below are some examples of active ongoing COVID-19 projects at BI.
Blood Coagulation and Fribinolysis
The Greineder Lab is studying the balance of coagulation and fibrinolysis in moderate-severe COVID-19 and to define its association with adverse clinical outcomes and abnormalities.
More about the Greineder Lab
Single Cell Analysis of Immune Cells
The Keller Lab and the Single Cell Core are currently working with collaborators on B-cell antibody response post-COVID infection in patients using single cell analysis approaches.
More about the Single Cell Core
Synthetic Protein Nanoparticles
The Lahann Lab is designing synthetic protein nanoparticles (sPNP) to deliver vectored antibody transgenes encoding broadly neutralizing antibodies against SARS CoV-2.
More about the Lahann Lab
Vaccine Research
The Moon Lab is working on vaccines for inducing protective immune responses against COVID-19. We will perform animal studies to identify our lead candidates.
More about the Moon Lab
Antibody Research
The Tessier Lab is currently working to define antibodies that potently recognize and neutralize the SARS-CoV-2 virus with the goal of accelerating therapeutic antibody and vaccine development.
More about the Tessier Lab
Chiral Nanoparticles
The Kotov Lab is investigating the applications of chiral nanoparticles and hedgehog particles for COVID-19 applications.
More about the Kotov Lab
Infection Spread Modeling
The Larson Lab is working with collaborators to apply their expertise in modeling percolation processes on networks and model COVID-19 infection spread.
More about the Larson Lab
Optical Sensor Platform
The Kim Lab has a well-established biosensor platform based on a conjugated polymer liposome system which produces color change and fluorescence development upon recognition of a target analyze. The sensory platform is readily available for modification and optimization for COVID19 detection.
More about the Kim Lab